November 2003
Bio-IT World;Nov2003, Vol. 2 Issue 11, p20
Academic Journal
Presents news on appointments and acquisitions within life sciences and pharmaceutical companies and related industries as of November 2003. Plan of GE Medical Systems to purchase Amersham PLC; Appointment of Mark Egerton as chief commercial officer and board member of Oxagen; Appointment of Paul J. Sekhri as president and chief business officer of ARIAD Pharmaceuticals.


Related Articles

  • GE Takes on the pharma Industry. Sellers, L.J. // Pharmaceutical Executive;Nov2003, Vol. 23 Issue 11, p20 

    Reports on the purchase of the Great Britain-based pharmaceutical company, Amersham PLC by General Electric Co. Merger of GE Medical Systems with Amersham to form GE Healthcare Technologies; Terms and details of the contract; Implications for medical care and developments in the industry.

  • For $9.5 billion, GE acquires Amersham.  // Healthcare Purchasing News;Nov2003, Vol. 27 Issue 11, p6 

    Reports on the decision of General Electric Co. (GE) to acquire the shares of diagnostic imaging agent and life sciences products manufacturer Amersham plc. Effect of the acquisition on the revenues of GE; Main business areas of Amersham; Background on the acquisition of Datex-Ohmeda by GE.

  • GE to Acquire U.K. Diagnostics and Drug Discovery Firm...  // Chemical Week;10/15/2003, Vol. 165 Issue 37, p4 

    Reports on the decision of General Electric to acquire diagnostics and drug discovery firm Amersham. Details of the acquisition deal; Value of the deal; Information on both companies.

  • ON THE MOVE.  // Pharmaceutical Technology Europe;Nov2003, Vol. 15 Issue 11, p72 

    Presents an update on key appointments. Appointment of Robert Misher as new chief operating officer of Almedica International; Recruitment of Mark Egerton as chief commercial officer of Oxagen; Selection of Gillian Walley as director of proposals and contracts of MDS Pharma Services; Appointment...

  • GE Medical snaps up Millbrook. Versel, Neil // Modern Physician;Jan2003, Vol. 7 Issue 1, p4 

    Reports on the acquisition by GE Medical Systems Information Technology on Millbrook Corp. in November 2002. Terms under the deal; Objective behind the move; Information on the healthcare software developed by GE Medical.

  • Aurora's USA Instruments fits image of GE med unit. Suttell, Scott // Crain's Cleveland Business;12/9/2002, Vol. 23 Issue 49, p3 

    Reports on the merger plans between USA Instruments Inc. and GE Medical Systems. Background of the companies; Discussion on the future plans of the companies following the merger.

  • The Week's Biggest Gainers and Losers.  // BioWorld Insight;6/13/2011, Vol. 19 Issue 24, p25 

    The article lists pharmaceutical companies including Ariad Pharmaceuticals Inc., Pharmasset Inc. and NeurogesX Inc. which figure among the 10 biggest gainers and losers at the stock market for the week till June 13, 2011.

  • Consolidation challenges in Europe's life science sector -- Making it happen. Stoiber, Wolfgang // Journal of Commercial Biotechnology;Sept2003, Vol. 10 Issue 1, p29 

    Even though the current market environment is tough on biotechnology companies, the number of consolidation transactions in Europe has fallen. Platform specialists have to turn themselves into product companies in order to be heard by investors. Product companies are crushed between high...

  • Still Breathing. Abejo, Jerry // Mergers & Acquisitions: The Dealermaker's Journal;Jun2008, Vol. 43 Issue 6, p64 

    The article reports that field of Life science merger and acquisition (M&A) has a belief that pharmaceutical dealings were immune to the deal market's ups and downs. It is averred that dealmakers are pressured to think long-term due to the patient and unsure nature of drug development. It is...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics